<DOC>
	<DOCNO>NCT01970995</DOCNO>
	<brief_summary>The main goal study evaluate ad libitum use THS 2.2 Menthol ( mTHS 2.2 ) 5 day confinement 85 day product use ambulatory setting , Japanese adult healthy smoker result reduction level biomarkers exposure select harmful potentially harmful smoke constituent ( HPHCs ) compare smoker continue smoking preferred brand menthol conventional cigarette ( mCC ) smoking abstinence ( SA ) . Smokers remain abstinent SA use benchmark provide context exposure reduction .</brief_summary>
	<brief_title>Reduced Exposure Study Using THS 2.2 Menthol With 5 Days Confinement Setting 85 Days Ambulatory Setting</brief_title>
	<detailed_description />
	<mesh_term>Menthol</mesh_term>
	<criteria>Subject Japanese . Smoking , healthy subject judge Investigator . Subject smoke least 10 commercially available mCCs per day ( brand restriction ) last 4 week , base selfreporting . Subject smoke least last 3 consecutive year . Subject plan quit smoke next 3 month . As per Investigator judgment , subject participate study reason ( e.g. , medical , psychiatric , and/or social reason ) . The subject receive medication within 14 day within 5 halflives medication ( whichever longer ) impact cytochrome P450 1 A2 ( CYP1A2 ) cytochrome P450 2 A6 ( CYP2A6 ) activity . For woman : Subject pregnant breast feeding . For woman : Subject agree use acceptable method effective contraception .</criteria>
	<gender>All</gender>
	<minimum_age>23 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Candidate modify risk tobacco product</keyword>
	<keyword>Conventional cigarette</keyword>
	<keyword>Reduced exposure</keyword>
	<keyword>HPHCs</keyword>
	<keyword>Ambulatory</keyword>
</DOC>